Digoxin Medulloblastoma Study
Evaluation of Digoxin for Relapsed Non-WNT, Non-SHH Medulloblastoma
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A PHASE2 clinical study on Medulloblastoma and Medulloblastoma, Non-WNT/Non-SHH, this trial is actively recruiting participants. The trial is conducted by H. Lee Moffitt Cancer Center and Research Institute and has accumulated 10 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Feb 2026 — Present [monthly]
Recruiting PHASE2
-
Jan 2026 — Feb 2026 [monthly]
Recruiting PHASE2
-
Dec 2025 — Jan 2026 [monthly]
Recruiting PHASE2
-
Oct 2025 — Dec 2025 [monthly]
Recruiting PHASE2
-
Sep 2025 — Oct 2025 [monthly]
Recruiting PHASE2
▶ Show 5 earlier versions
-
Jul 2025 — Sep 2025 [monthly]
Recruiting PHASE2
-
May 2025 — Jul 2025 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Mar 2025 — May 2025 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2025 — Mar 2025 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2024 — Jan 2025 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- H. Lee Moffitt Cancer Center and Research Institute
- National Pediatric Cancer Foundation
For direct contact, visit the study record on ClinicalTrials.gov .